- E-mail : info_marketing@jindunchemical.cn
- Phone : +86 21 64057580
- Address : Shanghai China
Preparation of aqueous dispersions of fluorinated hydroxyacrylic acid
High-solids solvent-based fluorinated acrylic acid resin was first prepared from fluorinated acrylic acid monomer, butyl methacrylate (BMA), butyl acrylate (BA) hydroxyethyl methac
READ MOREWhy do we need to add "water reducing agent" in cement? The effect is very big
Water reducing agent, as the name suggests, is to add it can reduce the amount of water admixture
READ MOREWater reducing agent: the main chemical in the cement industry, the industry chain leader to accelerate the concentration
Water reducing agent is a kind of concrete admixture that can reduce the amount of mixing water under the condition of maintaining the concrete slump basically unchanged.
READ MORECauses and solutions of deterioration of concrete polycarboxylic acid water reducing agent
Causes and solutions of deterioration of concrete polycarboxylic acid water reducing agent
READ MOREA collection of trivia about water reducing agents
Based on polycarboxylic acid water reducing agent, JINDUN CHEMICAL has developed special water reducing agent represented by bright water reducing agent
READ MOREHigh demand for empty capsules in the pharmaceutical field Empty capsules market size or will grow rapidly
High demand for empty capsules in the pharmaceutical field Empty capsules market size or will grow rapidly
READ MOREWhy is the absorption rate of enteric capsules higher?
Capsules can improve drug stability and bioavailability
READ MOREAzithromycin is not used right, beware of death!
Azithromycin is a commonly used antibacterial drug in respiratory medicine
READ MOREAPI [Sitagliptin] Drug Information, API Synthesis and Intermediates Diabetes Drug, Sitagliptin?
Sitagliptin (MK-0431) is an orally available, highly selective DPP-4 inhibitor with an IC50 of 18 nM.
READ MOREImproved synthesis process for the diabetes drug troglitazone succinate: minimizing impurity generation
Troglitazone succinate, a new oral DPP-4 inhibitor developed by Takeda Pharmaceuticals
READ MORE